| Literature DB >> 22228116 |
Sharonne de Zeeuw1, Usama Ahmed Ali, Usama Ahmed Ali, Rogier A R T Donders, Willem E Hueting, Frederik Keus, Cees J H M van Laarhoven.
Abstract
OBJECTIVE: The objective of this study is to provide a comprehensive update of the outcome of the ileo-pouch anal anastomosis (IPAA). DATA SOURCES: An extensive search in PubMed, EMBASE, and The Cochrane Library was conducted. STUDY SELECTION AND DATA EXTRACTION: All studies published after 2000 reporting on complications or functional outcome after a primary open IPAA procedure for UC or FAP were selected. Study characteristics, functional outcome, and complications were extracted. DATA SYNTHESIS: A review with similar methodology conducted 10 years earlier was used to evaluate developments in outcome over time. Pooled estimates were compared using a random-effects logistic meta-analyzing technique. Analyses focusing on the effect of time of study conductance, centralization, and variation in surgical techniques were performed.Entities:
Mesh:
Year: 2012 PMID: 22228116 PMCID: PMC3378834 DOI: 10.1007/s00384-011-1402-6
Source DB: PubMed Journal: Int J Colorectal Dis ISSN: 0179-1958 Impact factor: 2.571
Fig. 1Flowchart of study selection resulting in the 53 included studies
Definition of outcomes
| Pouch failure | Pouch excision or a nonfunctioning pouch at 12 months after IPAA |
| Pelvic sepsis | Pelvic abscess, anastomotic leakage or dehiscence, pelvic/perineal wound infection |
| Fistula | Any pouch-related fistula |
| Stricture | Anastomotic fibrosis necessitating dilatation |
| Mild fecal incontinence | Soiling, spotting in underwear |
| Severe fecal incontinence | Regularly severe leakage or fecal loss passive fecal incontinence |
Characteristics of studies and selected outcomes following IPAA in the 53 included studies published since 2000
| Author | Year of publication | Inclusion period | Number of patients | FU (months) | Age | Gender (% female) | Type of disease | Handsewn anastomosis (%) | With diverting ileostoma (%) |
|---|---|---|---|---|---|---|---|---|---|
| Fonkalsrud et al. [ | 2000 | 1993–1997 | 77 | 34.5 | 50 | UC | 57.1 | 100 | |
| Karlbom et al. [ | 2000 | 1983–1996 | 168 | 29 | 32 | 39.3 | UC | 58.9 | 70.8 |
| Seidel et al. [ | 2000 | 1985–1996 | 55 | 31.2 | 45.5 | Both | |||
| Simchuk [ | 2000 | 1987–1996 | 114 | 38 | 43.9 | Both | 100 | ||
| Gullberg and Liljeqvist [ | 2001 | 1990–1995 | 86 | 72 | 34.1 | 45.3 | Both | 2.3 | 10.5 |
| Barton et al. [ | 2001 | 1983–2000 | 110 | 30 | 36.8 | Both | 100 | 100 | |
| Heuschen et al. [ | 2001 | 1991–2000 | 171 | 30 | 36.7 | 45.6 | UC | 100 | 66.7 |
| Regimbeau et al. [ | 2001 | 1984–1998 | 172 | 60 | 36 | 47.1 | Both | 100 | 100 |
| Blumberg et al. [ | 2001 | 1982–1995 | 145 | 34 | 49 | Both | 15.2 | ||
| Dayton et al. [ | 2002 | 1982–2001 | 644 | 79 | 37.2 | 39.4 | UC | ||
| Rossi et al. [ | 2002 | 1989–2000 | 75 | 40 | 33.3 | Both | 54.7 | 100 | |
| Bullard et al. [ | 2002 | 1980–1992 | 154 | 151 | 34 | 44.2 | Both | 64 | |
| Gignoux et al. [ | 2002 | 1993–1998 | 84 | 22 | 33 | 42.9 | Both | 100 | |
| Mukhtar et al. [ | 2002 | 1990–1997 | 50 | 35 | 44 | Both | 2 | 98 | |
| Rudolph et al. [ | 2002 | 1991–1999 | 71 | 47 | 38 | 56 | UC | 84.5 | |
| Carmon et al. [ | 2003 | 1990–2001 | 77 | 51 | 38 | 55.8 | UC | 72.7 | |
| Teixeira et al. [ | 2003 | 1986–2000 | 80 | 108 | 50 | UC | 11.3 | 77.5 | |
| Michelassi et al. [ | 2003 | 1987–2002 | 391 | 37 | 33.7 | 44.2 | Both | 29.9 | 65 |
| Holubar and Hyman [ | 2003 | 51 | 85 | 42.1 | 51 | UC | 70.6 | ||
| Fowler et al. [ | 2003 | 1984–2001 | 106 | 40 | 50 | Both | 39.4 | 41.3 | |
| Parc et al. [ | 2004 | 1983–1990 | 110 | 175 | 26.5 | 43.6 | FAP | 100 | |
| Lin et al. [ | 2004 | 1985–2002 | 61 | 60 | 37 | 54 | Both | 67.2 | |
| Hueting et al. [ | 2004 | 1989–2000 | 111 | 42 | 35.4 | 68.5 | UC | ||
| Gosselink et al. [ | 2004 | 1989–2001 | 127 | 56 | 36 | 42.5 | UC | 21.6 | |
| Krausz et al. [ | 2005 | 1984–2004 | 174 | 64 | 34.1 | 47.7 | Both | 54 | 87.4 |
| Hallberg et al. [ | 2005 | 1990–1997 | 100 | 53 | 32 | 39 | UC | 17 | |
| Swenson et al. [ | 2005 | 1995–2003 | 54 | 22 | 35 | 35.2 | 57.4 | ||
| Chapman et al. [ | 2005 | 1981–2000 | 2002 | 121 | 33.5 | 46.6 | Both | 5 | |
| Kok Sun Ho et al. [ | 2005 | 1989–2001 | 330 | 32 | 59.1 | UC | |||
| Ikeuchi et al. [ | 2005 | 1999–2003 | 242 | 32.1 | 50.8 | UC | 100 | 38 | |
| Arai et al. [ | 2005 | 1993–2003 | 296 | 53 | 33.8 | 43.2 | UC | 96.3 | 55.4 |
| Araki et a l. [ | 2006 | 1998–2003 | 220 | 34.5 | 46.8 | Both | 47.3 | ||
| Rickard et al. [ | 2006 | 1982–2002 | 516 | 33 | 45.2 | Both | 32.4 | 88 | |
| Bednarz et al. [ | 2007 | 1994–2005 | 108 | 60 | 50 | Both | 18.5 | 100 | |
| Berndtsson et al. [ | 2007 | 1982–1995 | 370 | 180 | 34 | 45.7 | UC | ||
| Gualdrini et al. [ | 2007 | 1987–2005 | 391 | 45.6 | 35.4 | 51.7 | Both | ||
| Kiran et al. [ | 2008 | 2016 | 180 | 37.7 | 43.9 | Both | 15.4 | 85.9 | |
| Tulchinsky et al. [ | 2008 | 1986–2005 | 211 | 124.6 | 35.4 | 58.3 | UC | 16.5 | 79 |
| Walker and Bulow [ | 2008 | 1987–2004 | 178 | 84 | 31 | 44.9 | Both | 6.7 | 100 |
| Ferrante et al. [ | 2008 | 1990–2004 | 173 | 78 | 39 | 38.7 | UC | 2.3 | 85 |
| Leal et al. [ | 2008 | 1984–2006 | 69 | 82 | 29.6 | 59.4 | FAP | 100 | 100 |
| Zarate et al. [ | 2008 | 1984–2006 | 107 | 34.4 | 57 | Both | 12.1 | 100 | |
| Pinto et al. [ | 2009 | 2001–2008 | 66 | 21.1 | 52.8 | 66.7 | Both | 18.2 | 100 |
| Leowardi et al. [ | 2009 | 1988–1996 | 197 | 147.6 | 33 | 45.2 | UC | 100 | 100 |
| Norwood et al. [ | 2009 | 1997–2007 | 107 | 77 | 38 | 45.8 | Both | 99 | |
| Loftus et al. [ | 2009 | 2001–2005 | 237 | 5.9 | 38.9 | 45 | UC | ||
| Tekkis et al. [ | 2009 | 1976–2006 | 2491 | 74.4 | 35.9 | 47.9 | Both | 33.3 | 67.3 |
| Scarpa et al. [ | 2009 | 1984–2004 | 58 | 136 | 38 | 34.5 | UC | 0 | |
| Wasmuth et al. [ | 2009 | 1984–2006 | 304 | 120 | 34.4 | 38.8 | Both | 40.1 | 84 |
| Andersson et al. [ | 2009 | 1984–2003 | 110 | 144 | 35 | 45.5 | Both | 47.3 | |
| Fichera et al. [ | 2009 | 2002–2007 | 106 | 24.8 | 36.9 | 42.2 | UC | 71.6 | |
| Rink et al. [ | 2009 | 1990–2002 | 131 | 85 | 33 | 46.6 | UC | 84 | |
| Pricolo [ | 2009 | 1991–2008 | 312 | 36 | 46.8 | Both | 8 |
Fig. 2Proportions of pouch failure following an IPAA procedure in studies published since 2000. The size of the dot correlates with the population size of the study. The lines represent the 95% CI. The pooled incidence of all studies is 4.3%
Fig. 3Proportions of pelvic sepsis following an IPAA procedure in studies published since 2000. The size of the dot correlates with the population size of the study. The lines represent the 95% CI. The pooled incidence of all studies is 7.5%
Pooled incidences of complications and functional outcome following an IPAA procedures in studies published since 2000 compared to studies published before 2000
| Since 2000 | Before 2000 |
| |||||
|---|---|---|---|---|---|---|---|
| Number of studies | Number of patients | Pooled incidences | Number of studies | No. of patients | Pooled incidences | ||
| Complications | % (95% CI) | % (95%CI) | |||||
| Pouch failure | 43 | 13,249 | 4.3 (3.5–5.3) | 39 | 8,877 | 6.8 (5.8–8.4) | 0.0038 |
| Pouch failure: FU > 5 years | 22 | 9,873 | 4.7 (3.4–6.4) | 11 | 3,198 | 8.5 (5.4–13.2) | |
| Pelvic sepsis | 46 | 13,450 | 7.5 (6.1–9.1) | 41 | 9,082 | 9.5 (8.2–10.9) | NS |
| Fistula | 38 | 12,398 | 4.5 (3.5–5.7) | 30 | 5,120 | 5.5 (4.3–7.0) | NS |
| Stricture | 35 | 12,219 | 10.7 (8.2–13.8) | 28 | 5,185 | 9.2 (6.8–12.4) | NS |
| Pouchitis | 39 | 12,685 | 26.8 (21.0–33.5) | 33 | 7,289 | 18.8 (15.7–22.4) | NS |
| Sexual dysfunction | 13 | 6,131 | 3.0 (1.7–5.2) | 21 | 5,112 | 3.6 (2.7–4.7) | NS |
| Small bowel obstruction | 34 | 11,895 | 11.4 (9.1–14.1) | 27 | 5,853 | 13.1 (11.0–15.7) | NS |
| Fecal incontinence | %(95%CI) | % (95%CI) | |||||
| Mild day incontinence | 21 | 6,988 | 14.3 (7.3–25.9) | 31 | 4,313 | 17.0 (12.8–22.2) | NS |
| Severe day incontinence | 13 | 3,718 | 6.1 (2.9–12.3) | 27 | 3,914 | 3.7 (2.8–4.8) | NS |
| Mild night incontinence | 9 | 5,423 | 17.3 (4.7–46.8) | 17 | 2,582 | 13.1 (9.5–17.9) | NS |
| Severe night incontinence | 10 | 3,614 | 7.6 (2.5–21.3) | 9 | 1,271 | 4.5 (3.0–6.7) | NS |
| Frequency | Mean (95%CI) | Mean (95%CI) | |||||
| Frequency day | 26 | 5,321 | 5.7 (4.9–6.7) | 13 | 2,277 | 5.2 (4.0–6.7) | NS |
| Frequency night | 22 | 7,117 | 1.5 (1.0–2.1) | 20 | 2,950 | 1.0 (0.6–1.6) | NS |
| Frequency 24 h | 26 | 5,132 | 5.9 (5.0–6.9) | 20 | 3,547 | 5.2 (4.4–6.1) | NS |
CI confidence interval, FU follow-up period
Fig. 4Scatter plot depicting the median year of inclusion and the rate of pouch failure of studies included in both reviews
Fig. 5Error bar chart depicting the median rate of pouch failure compared to the median year of inclusion (divided into interquartile ranges)
Fig. 6Relationship between moment of study conductance (median year of inclusion) and inclusion rate of patients, divided in the past three decades